|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
G1 Therapeutics Inc (GTHX) |
|
|
$7.15 0.00 (0.00%) as of 4:30 Fri 9/13
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
38,010,000 |
| Market
Cap: |
271.77(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$2.2 - $7.15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of patients with cancer. Co.'s primary compound trilaciclib is a therapy designed to help protect against chemotherapy-induced myelosuppression. Trilaciclib helps protect hematopoietic stem and progenitor cells in the bone marrow by transiently inhibiting CDK4/6 leading to a temporary arrest of susceptible host cells during chemotherapy in patients. Rintodestrant is an oral selective estrogen receptor degrader for the treatment of ER+ breast cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
100,953 |
295,121 |
| Total Sell Value |
$0 |
$0 |
$441,373 |
$1,032,937 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
13 |
32 |
| End Date |
2025-02-02 |
2024-11-01 |
2024-05-03 |
2023-05-04 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bailey John E. (jack) Jr. |
President and CEO |
• • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(196,287) |
0 |
|
- |
|
| Bailey John E. (jack) Jr. |
President and CEO |
• • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(534,787) |
196,287 |
|
- |
|
| Bailey John E. (jack) Jr. |
President and CEO |
• • – |
2024-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
181,400 |
731,074 |
|
- |
|
| Muir Glenn P |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(185,358) |
0 |
|
- |
|
| Muir Glenn P |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
185,358 |
|
- |
|
| Nicholson Garry A |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,389) |
0 |
|
- |
|
| Nicholson Garry A |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
14,389 |
|
- |
|
| Secor Alicia |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
|
- |
|
| Secor Alicia |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
10,000 |
|
- |
|
| Sharpless Norman |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
0 |
|
- |
|
| Avagliano Mark |
Chief Business Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,035) |
0 |
|
- |
|
| Avagliano Mark |
Chief Business Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(236,610) |
26,035 |
|
- |
|
| Avagliano Mark |
Chief Business Officer |
• – – |
2024-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
20,600 |
262,645 |
|
- |
|
| Lee Jacks |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
|
- |
|
| Lee Jacks |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
10,000 |
|
- |
|
| Schwalm Cynthia |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,889) |
0 |
|
- |
|
| Schwalm Cynthia |
|
– • – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,000) |
15,889 |
|
- |
|
| Malik Rajesh |
Chief Medical Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(87,450) |
0 |
|
- |
|
| Malik Rajesh |
Chief Medical Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(89,762) |
87,450 |
|
- |
|
| Malik Rajesh |
Chief Medical Officer |
• – – |
2024-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
17,900 |
177,212 |
|
- |
|
| Perry Andrew |
Chief Commercial Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(14,232) |
0 |
|
- |
|
| Perry Andrew |
Chief Commercial Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(114,482) |
14,232 |
|
- |
|
| Perry Andrew |
Chief Commercial Officer |
• – – |
2024-09-18 |
4 |
A |
$0.00 |
$0 |
D/D |
16,100 |
128,714 |
|
- |
|
| Murdock Terry L |
Chief Operating Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(21,150) |
0 |
|
- |
|
| Murdock Terry L |
Chief Operating Officer |
• – – |
2024-09-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(124,762) |
21,150 |
|
- |
|
383 Records found
|
|
Page 1 of 16 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
